Congress moves to block insurers from cutting dialysis coverage
H.R. 2199 — Restore Protections for Dialysis Patients Act · Filed by Mike Kelly (R-PA) · 76 cosponsors · Introduced Mar 18, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends Medicare law to strengthen protections for dialysis patients by prohibiting private health insurance plans from treating end-stage renal disease (ESRD) or dialysis services less favorably than other medical services. The bill clarifies that plans cannot single out dialysis for coverage limits or restrictions that disproportionately harm ESRD patients, though plans retain the right to choose which dialysis providers to include in their networks. The intent is to prevent private insurers from shifting the cost burden of dialysis care onto Medicare.
Why we flagged it
The bill's core function is to strengthen anti-discrimination protections for a specific patient population (ESRD/dialysis patients) against private insurers, using Medicare law as the enforcement mechanism. It is regulatory in nature, not a subsidy or appropriation.
What the text implies
- The bill may increase private insurers' costs by restricting their ability to limit dialysis coverage, potentially leading to higher premiums or reduced plan offerings in dialysis-heavy markets.
- Enforcement through Part 411 CFR (nonconformance determinations) delegates authority to HHS/CMS to define what constitutes 'disparate effect'—regulatory interpretation will determine the bill's actual scope.
The full analysis lists 3 implications of this text.
Who stands to gain
dialysis patients (reduced out-of-pocket costs, broader coverage); dialysis service providers (increased patient volume and insurance reimbursement)